FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306765286> ?p ?o ?g. }

• W4306765286 endingPage "6131" @default.
• W4306765286 startingPage "6131" @default.
• W4306765286 abstract "Controlled ovarian hyperstimulation (COH) is essential for the success of in vitro fertilization (IVF). Evidence showing the comparison of different COH protocols remains predominantly of low certainty and derives from unspecified infertile and highly heterogeneous populations. Thus, personalized approaches to examine the response of patients to the various COH protocols need to be investigated. Data from in vitro and animal studies have identified the mechanistic target of rapamycin (mTOR) and Hippo signaling pathways play a key role in follicular homeostasis and oocyte quality. To be specific, current data indicate the controlled activation of mTOR and the controlled inhibition of the Hippo pathway within the ovarian granulosa cells (GC). Both are reported to lead to a nurturing follicular microenvironment, increase oocyte quality, and potentially improve reproductive outcomes. As intracellular markers, phosphorylated/unphosphorylated levels of the pathways’ main downstream mediators could be included among the candidate “personalized” predictors of patients’ response to COH protocols and final IVF outcomes. Based on these hypotheses, we make a preliminary attempt to investigate their validity: We propose a prospective cohort study to compare the levels of certain phosphorylated/unphosphorylated components of the investigated pathways (mTOR, ribosomal protein S6 kinase beta-1 (p70S6K-1), yes-associated protein-1 (YAP-1), and transcriptional coactivator with PDZ-binding motif (TAZ)) within the follicular fluid-isolated GC between women undergoing gonadotropin-releasing hormone (GnRH) antagonist/“short” protocols and those receiving GnRH agonist/“long 21” protocols. A case-control design comparing these levels between women achieving pregnancy and those who did not is further planned. Additional analyses addressing the population’s expected heterogeneity are planned after the completion of the pilot phase, during which 100 participants undergoing IVF are intended to be recruited. At this stage, these hypotheses are solely based on in vitro/animal data, and thus, similar studies on humans in this respect are necessary for the investigation of their potential validity." @default.
• W4306765286 created "2022-10-19" @default.
• W4306765286 creator A5023508584 @default.
• W4306765286 creator A5027706277 @default.
• W4306765286 creator A5027874206 @default.
• W4306765286 creator A5033430460 @default.
• W4306765286 creator A5058376201 @default.
• W4306765286 creator A5072491193 @default.
• W4306765286 date "2022-10-18" @default.
• W4306765286 modified "2023-09-25" @default.
• W4306765286 title "The Effect of Stimulation Protocols (GnRH Agonist vs. Antagonist) on the Activity of mTOR and Hippo Pathways of Ovarian Granulosa Cells and Its Potential Correlation with the Outcomes of In Vitro Fertilization: A Hypothesis" @default.
• W4306765286 cites W1600600005 @default.
• W4306765286 cites W1897925090 @default.
• W4306765286 cites W1976153964 @default.
• W4306765286 cites W2025971753 @default.
• W4306765286 cites W2032228150 @default.
• W4306765286 cites W2046396172 @default.
• W4306765286 cites W2050527917 @default.
• W4306765286 cites W2096850799 @default.
• W4306765286 cites W2101304900 @default.
• W4306765286 cites W2109997796 @default.
• W4306765286 cites W2115742485 @default.
• W4306765286 cites W2122998411 @default.
• W4306765286 cites W2124556975 @default.
• W4306765286 cites W2129482290 @default.
• W4306765286 cites W2138674040 @default.
• W4306765286 cites W2147196233 @default.
• W4306765286 cites W2148145541 @default.
• W4306765286 cites W2153813779 @default.
• W4306765286 cites W2167154418 @default.
• W4306765286 cites W2256848479 @default.
• W4306765286 cites W2326748274 @default.
• W4306765286 cites W2327842639 @default.
• W4306765286 cites W2425569665 @default.
• W4306765286 cites W2460203703 @default.
• W4306765286 cites W2465694018 @default.
• W4306765286 cites W2517550193 @default.
• W4306765286 cites W2578687948 @default.
• W4306765286 cites W2589910211 @default.
• W4306765286 cites W2620316103 @default.
• W4306765286 cites W2778796650 @default.
• W4306765286 cites W2783283173 @default.
• W4306765286 cites W2792543365 @default.
• W4306765286 cites W2801098359 @default.
• W4306765286 cites W2801707590 @default.
• W4306765286 cites W2804054946 @default.
• W4306765286 cites W2810164359 @default.
• W4306765286 cites W2884303503 @default.
• W4306765286 cites W2898719924 @default.
• W4306765286 cites W2938891495 @default.
• W4306765286 cites W2939459765 @default.
• W4306765286 cites W2945230631 @default.
• W4306765286 cites W2953039196 @default.
• W4306765286 cites W2969008798 @default.
• W4306765286 cites W2974481299 @default.
• W4306765286 cites W2994602954 @default.
• W4306765286 cites W2997052818 @default.
• W4306765286 cites W3021687588 @default.
• W4306765286 cites W3031983837 @default.
• W4306765286 cites W3034406181 @default.
• W4306765286 cites W3046588085 @default.
• W4306765286 cites W3102856167 @default.
• W4306765286 cites W3129275164 @default.
• W4306765286 cites W3150169962 @default.
• W4306765286 cites W3187054958 @default.
• W4306765286 cites W3192215542 @default.
• W4306765286 cites W3216045370 @default.
• W4306765286 cites W4210419327 @default.
• W4306765286 cites W4210784847 @default.
• W4306765286 cites W4220828915 @default.
• W4306765286 cites W4280608532 @default.
• W4306765286 cites W4281258398 @default.
• W4306765286 cites W4281683933 @default.
• W4306765286 cites W4283719341 @default.
• W4306765286 doi "https://doi.org/10.3390/jcm11206131" @default.
• W4306765286 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36294452" @default.
• W4306765286 hasPublicationYear "2022" @default.
• W4306765286 type Work @default.
• W4306765286 citedByCount "1" @default.
• W4306765286 countsByYear W43067652862023 @default.
• W4306765286 crossrefType "journal-article" @default.
• W4306765286 hasAuthorship W4306765286A5023508584 @default.
• W4306765286 hasAuthorship W4306765286A5027706277 @default.
• W4306765286 hasAuthorship W4306765286A5027874206 @default.
• W4306765286 hasAuthorship W4306765286A5033430460 @default.
• W4306765286 hasAuthorship W4306765286A5058376201 @default.
• W4306765286 hasAuthorship W4306765286A5072491193 @default.
• W4306765286 hasBestOaLocation W43067652861 @default.
• W4306765286 hasConcept C126322002 @default.
• W4306765286 hasConcept C134018914 @default.
• W4306765286 hasConcept C16685009 @default.
• W4306765286 hasConcept C170493617 @default.
• W4306765286 hasConcept C172512520 @default.
• W4306765286 hasConcept C187785154 @default.
• W4306765286 hasConcept C196843134 @default.
• W4306765286 hasConcept C2776690073 @default.
• W4306765286 hasConcept C2778938600 @default.
• W4306765286 hasConcept C512716672 @default.

• next